1. Home
  2. BNL vs OGN Comparison

BNL vs OGN Comparison

Compare BNL & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNL
  • OGN
  • Stock Information
  • Founded
  • BNL 2007
  • OGN 1923
  • Country
  • BNL United States
  • OGN United States
  • Employees
  • BNL N/A
  • OGN N/A
  • Industry
  • BNL Real Estate Investment Trusts
  • OGN Biotechnology: Pharmaceutical Preparations
  • Sector
  • BNL Real Estate
  • OGN Health Care
  • Exchange
  • BNL Nasdaq
  • OGN Nasdaq
  • Market Cap
  • BNL 3.0B
  • OGN 2.5B
  • IPO Year
  • BNL 2020
  • OGN N/A
  • Fundamental
  • Price
  • BNL $16.82
  • OGN $9.21
  • Analyst Decision
  • BNL Hold
  • OGN Hold
  • Analyst Count
  • BNL 6
  • OGN 4
  • Target Price
  • BNL $18.33
  • OGN $18.00
  • AVG Volume (30 Days)
  • BNL 1.4M
  • OGN 4.4M
  • Earning Date
  • BNL 07-30-2025
  • OGN 08-05-2025
  • Dividend Yield
  • BNL 6.90%
  • OGN 0.87%
  • EPS Growth
  • BNL N/A
  • OGN N/A
  • EPS
  • BNL 0.52
  • OGN 2.69
  • Revenue
  • BNL $442,203,000.00
  • OGN $6,281,000,000.00
  • Revenue This Year
  • BNL $4.37
  • OGN N/A
  • Revenue Next Year
  • BNL $5.87
  • OGN $1.02
  • P/E Ratio
  • BNL $32.40
  • OGN $3.43
  • Revenue Growth
  • BNL 3.85
  • OGN N/A
  • 52 Week Low
  • BNL $13.96
  • OGN $8.01
  • 52 Week High
  • BNL $19.15
  • OGN $23.10
  • Technical
  • Relative Strength Index (RSI)
  • BNL 63.96
  • OGN 43.79
  • Support Level
  • BNL $16.64
  • OGN $8.32
  • Resistance Level
  • BNL $16.95
  • OGN $10.31
  • Average True Range (ATR)
  • BNL 0.31
  • OGN 0.46
  • MACD
  • BNL 0.11
  • OGN -0.10
  • Stochastic Oscillator
  • BNL 89.45
  • OGN 43.13

About BNL Broadstone Net Lease Inc.

Broadstone Net Lease Inc is an internally managed real estate investment trust that invests in, owns, and manages single-tenant commercial real estate properties that are net leased on a long-term basis to a diversified group of tenants. The company has selectively invested in net leased assets in the industrial, healthcare, restaurant, retail, and office property types. The company focuses on investing in real estate that is operated by creditworthy single tenants in industries characterized by positive business drivers and trends. The company targets properties that are an integral part of the tenants' businesses and are therefore opportunities to secure long-term net leases.

About OGN Organon & Co.

Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.

Share on Social Networks: